CIK 0001472091 · Non-accelerated filer<br>Smaller reporting company
PDS Biotechnology Corp
Sign in to watch- Ticker
- PDSB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 264231384
- Phone
- 800-208-3343
- Business address
- 303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- Edge Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-15 | BEDU-ADDO FRANK President/CEO | Shares withheld for taxes | −27,166 | $12.86 | $349K | 646,515 |
| 2021-06-15 | BEDU-ADDO FRANK President/CEO | Option exercise · Stock Option (Right to Buy) | −53,174 | 0 | ||
| 2021-06-15 | Glover Steve C Director | Purchase | +5,882 | $8.50 | $50K | 63,790 |
| 2021-06-15 | Ali-Jackson Kamil Director | Purchase | +11,764 | $8.50 | $100K | 11,764 |
| 2021-06-15 | VAN VOORHEES SETH Chief Financial Officer | Purchase | +17,647 | $8.50 | $150K | 17,647 |
| 2021-06-15 | Freitag Gregory Gene Director | Purchase | +5,882 | $8.50 | $50K | 46,153 |
| 2021-01-04 | VAN VOORHEES SETH Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +202,800 | 202,800 | ||
| 2020-12-08 | CONN GREGORY Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +122,400 | 122,400 | ||
| 2020-12-08 | WOOD LAUREN Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +210,500 | 210,500 | ||
| 2020-12-08 | King Michael N. Interim CFO | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2020-12-08 | BEDU-ADDO FRANK President/CEO | Grant or award · Stock Option (Right to Buy) | +707,800 | 707,800 | ||
| 2020-11-03 | BRAWLEY OTIS W Director | Grant or award · Stock Option (Right to Buy) | +9,000 | 9,000 | ||
| 2020-06-23 | Glover Steve C Director | Grant or award · Stock Option (Right to Buy) | +9,000 | 9,000 | ||
| 2020-06-23 | Freitag Gregory Gene Director | Grant or award · Stock Option (Right to Buy) | +9,000 | 9,000 | ||
| 2020-06-23 | SYKES RICHARD Director | Grant or award · Stock Option (Right to Buy) | +9,000 | 9,000 | ||
| 2020-06-23 | Ali-Jackson Kamil Director | Grant or award · Stock Option (Right to Buy) | +3,033 | 3,033 | ||
| 2020-06-23 | WOOD LAUREN Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +35,000 | 35,000 | ||
| 2020-06-23 | Bloomquist DeLyle W Director | Grant or award · Stock Option (Right to Buy) | +9,000 | 9,000 | ||
| 2020-06-23 | Iliev Ilian Director | Grant or award · Stock Option (Right to Buy) | +1,874 | 1,874 | ||
| 2020-06-23 | CONN GREGORY Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +35,000 | 35,000 |
Page 5 of 6 · 118 trades